Century Therapeutics (IPSC) Net Cash Flow (2020 - 2026)
Century Therapeutics (IPSC) reported Net Cash Flow of -$11.3 million for Q1 2026, down 71.22% year-over-year from -$39.1 million in Q1 2025, and down 277.59% quarter-over-quarter from $6.3 million in Q4 2025.
Century Therapeutics (IPSC) Net Cash Flow (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Net Cash Flow data on file, last reported at -$11.3 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$11.3 million, down 71.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$883000.0 (down 115.1% YoY), and the FY2025 annual result was $3.8 million, down 68.11% from the prior year.
- Net Cash Flow declined to -$11.3 million in Q1 2026 per IPSC's latest filing, from $6.3 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $69.6 million in Q1 2022 and troughed at -$27.1 million in Q4 2022.
- A 5-year average of -$259117.6 and a median of -$1.4 million in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow jumped 221.99% in 2024, then tumbled 1183.79% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$27.1 million in 2022, then surged by 70.53% to -$8.0 million in 2023, then jumped by 172.42% to $5.8 million in 2024, then climbed by 9.62% to $6.3 million in 2025, then tumbled by 277.59% to -$11.3 million in 2026.
- Business Quant data shows IPSC's Net Cash Flow at -$11.3 million in Q1 2026, $6.3 million in Q4 2025, and -$913000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | -11.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.25 Mn |
| Mar 31, 2026 | -11.25 Mn |
| Dec 31, 2025 | 6.34 Mn |
| Dec 31, 2025 | 6.34 Mn |
| Sep 30, 2025 | -913,000.00 |
| Sep 30, 2025 | -913,000.00 |
| Jun 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 4.95 Mn |
| Mar 31, 2025 | -6.57 Mn |
| Mar 31, 2025 | -6.57 Mn |
| Dec 31, 2024 | 5.78 Mn |
| Dec 31, 2024 | 5.78 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Jun 30, 2024 | -4.50 Mn |
| Jun 30, 2024 | -4.50 Mn |
| Mar 31, 2024 | -512,000.00 |
| Mar 31, 2024 | -512,000.00 |
| Dec 31, 2023 | -7.98 Mn |
| Dec 31, 2023 | -7.98 Mn |